UNITED
STATES
|
||||||||
SECURITIES
AND EXCHANGE COMMISSION
|
||||||||
WASHINGTON,
DC 20549
|
||||||||
FORM
8-K
|
||||||||
CURRENT
REPORT
|
||||||||
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
|
||||||||
Date
of report (Date of earliest event reported):
|
November
25, 2008
|
|||||||
CHINA
SKY ONE MEDICAL, INC.
|
||||||||
(Exact
Name of Registrant as Specified in Charter)
|
||||||||
Nevada
|
000-26059
|
87-0430322
|
||||||
(State
or Other Jurisdiction
of
Incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
||||||
Room
1706, No. 30 Di Wang Building, Gan Shui Road,
Nangang
District, Harbin, People’s Republic of China 150001
|
||||||||
(Address
of Principal Executive Offices)
|
||||||||
Registrant's
telephone number, including area code:
|
86-451-53994073
(China)
|
|||||||
(Former
Name or Former Address, if Changed Since Last Report)
|
||||||||
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under
any
of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities
Act (17
CFR 230.425)
oSoliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
oPre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
oPre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
Item
5.02.
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment
of
Certain Officers; Compensatory Arrangements of Certain
Officers.
|
Item 7.01. |
Regulation
FD Disclosure
|
Item 9.01. |
Financial
Statements and Exhibits
|
Exhibit
No.
|
Description
|
|
99.1
|
Press
Release
|
CHINA
SKY ONE MEDICAL, INC.
|
||||
(Registrant)
|
||||
Date:
|
December
2, 2008
|
By:
|
/s/
Yan-qing Liu
|
|
Yan-qing
Liu
|
||||
Chairman,
Chief Executive Officer and
President
|